Preliminary program now available!
The APLAR 2023 official program is scheduled in the Chiang Mai time zone (GMT+7). To check the program times in your location, use our time zone converter.
As more information becomes available – this page will be updated so please make sure to check back regularly.
|
0800 |
REGISTRATION |
|
|
0830-0900 |
1st APLAR Endorsed Course of Musculoskeletal Ultrasound Workshop – basic level | Day 1 Workshop begins at 0830. View information here |
|
|
0900-1200 |
|
|
|
1200-1245 |
BREAK |
|
|
1245-1445 |
1st APLAR Endorsed Course of Musculoskeletal Ultrasound Workshop – basic level | Day 1 Continued |
MRI Axial Imaging Course Continued |
|
1445-1515 |
BREAK |
|
|
1515-1700 |
1st APLAR Endorsed Course of Musculoskeletal Ultrasound Workshop – basic level | Day 1 Continued - Workshop finishes at 1700 for this day. |
MRI Axial Imaging Course Course finishes at 1600. |
|
0800-0830 |
REGISTRATION |
||
|
0830-0900 |
1st APLAR Endorsed Course of Musculoskeletal Ultrasound Workshop – basic level | Day 2 Continued - Workshop begins at 0830. View information here |
|
|
|
0900-1000 |
|
|
|
|
1000 -1030 |
BREAK |
||
|
1030 -1200 |
1st APLAR Endorsed Course of Musculoskeletal Ultrasound Workshop – basic level | Day 2 Continued |
GRAPPA Symposium Symposium finishes at 1200. |
mRSS Assessment Course
Course finishes at 1200. |
|
1200 -1245 |
BREAK |
||
|
1245 -1400 |
1st APLAR Endorsed Course of Musculoskeletal Ultrasound Workshop – basic level | Day 2 Continued - Workshop continues until 1700. |
|
Changing and perspective of academic journals Course begins at 1245, and finishes at 1400. View information here |
|
1700-1800 |
Opening Ceremony Included in registration. View more information here |
||
|
1800-1930 |
Welcome Reception and Official Opening of Exhibition Hall Included in registration. View more information here |
||
|
ROOM Capacity |
B7 150 theatre capacity |
B2 50 classroom capacity |
B8 150 classroom capacity |
B9 250 theatre capacity |
-- Info coming soon |
B3 100 classroom capacity |
B4 100 classroom capacity |
B5 100 classroom capacity |
A2 30 u-shape |
|---|---|---|---|---|---|---|---|---|---|
|
0830-0900 |
REGISTRATION |
||||||||
|
0900-1000 |
Cont. MSUS Workshop Day 2 |
Cont. MRI Imaging Course Day 2 |
GRAPPA Symposium |
Allied Health Course |
|
APLAR Industry workshop 1 set up |
APLAR Industry workshop 2 set up |
APLAR Industry workshop 3 set up |
APLAR Executive Committee Meeting |
|
1000 -1030 |
COFFEE BREAK |
COFFEE BREAK |
|||||||
|
1030 -1200 |
Cont. MSUS Workshop Day 2 |
Cont. MRI Imaging Course Day 2 |
Cont. GRAPPA Symposium |
Cont. Allied Health Course |
APLAR Meetings |
||||
|
1200 -1245 |
LUNCH BREAK |
LUNCH BREAK |
|||||||
|
1245 -1400 |
Cont. MSUS Workshop Day 2 |
Cont. MRI Imaging Course Day 2 |
Cont. GRAPPA Symposium |
Cont. Allied Health Course |
APLAR Meetings |
||||
|
1400-1700 |
|
AFTERNOON TEA |
|||||||
|
Industry pre-congress workshop 1 |
Industry pre-congress workshop 2 |
Industry pre-congress workshop 3 |
APLAR Meetings |
||||||
|
ROOM Capacity |
PLENARY/CONCURRENT 1 - Exhibition Hall 1 2,000 capacity |
||||||||
|
1700-1800 |
Opening Ceremony |
||||||||
|
ROOM Capacity |
Exhibition Hall 3 - exhibition |
||||||||
|
1800-1930 |
Welcome Reception and Official Opening of Exhibition Hall |
||||||||
|
0800-0930 |
Plenary session 1
Chairpersons: Catherine Hill and Masayoshi Harigai Update treatment in Behcet's disease Wafa Madanat TBA Xinping Tian Geo-ethnic variations in vasculitis disease Debashish Danda |
||||
|
0930-1030 |
Plenary session 2
Chairpersons: Ho So What do we mean about the nature of scleroderma disease from the EU-US and Asia-Pacific database? Andrea Low Update of guidelines on treatments of interstitial lung disease in connective tissue diseases from ERS/EULAR Oliver Distler |
||||
|
1030-1055 |
BREAK AND POSTER VIEWING |
||||
|
1055-1200 |
Morning symposium 1 |
Morning symposium 2 |
Morning symposium 3 |
|
|
|
1200-1315 |
SpA / PsA session
Chairpersons: Nazrul Islam and Muhammad Ahmed Saeed Juvenile SpA: pathogenisis, assessment and outcome Amita Aggarwal Gut dysbiosis in axial spondyloarthritis Hong Ki Min Q&A |
Large vessel vasculitis 2023 update
Coordinated by the APLAR Vasculitis SIG Chairpersons: Debashish Danda Epidemiology and clinical features of GCA Catherine Hill Management of GCA Frank Butthereit Takayasu arteritis and reproduction Takako Miyamae Panel discussion Catherine Hill, Frank Butthereit, Takako Miyamae and Masayoshi Harigai Closing remarks Debashish Danda |
Scleroderma session
Coordinated by the APLAR Scleroderma SIG Chairpersons: Andrea Low and Jasmin Raja Novel therapies in SSc and lessons learnt from clinical trials Oliver Distler Bridging the valley of death from bench to bedside in systemic sclerosis Tohru Takeuchi Q&A A challenging therapeutic case of SSc panel discussion ChingChing Foocharoen, Oliver Distler and Tohru Takeuchi |
Insight antiphospholipid syndrome and associated diseases
Chairpersons: Sami Salmon and Kenji Oku Update in pathogenesis and relevance antibodies Takao Koike Controversy of APS in SLE Laniyati Hamijoyo Clinical features and treatments in interferon-driven APS-SLE Yoshiya Tanaka |
|
|
1315-1435 |
Lunch symposium 1 |
Lunch symposium 1 |
|
|
|
|
BREAK AND POSTER VIEWING |
|||||
|
1435-1550 |
Axial manifestation of psoriatic arthritis
Chairpersons: Sang-Heon Lee and Praveena Chiowchanwisawakit Clinical features of axial manifestation of psoriatic arthritis Ved Chaturvedi TBA Katy Leung Treatment of axial PsA Lai-Shan Tam |
Myositis session
Coordinated by the APLAR myositis SIG Chairpersons: Iris Tang and Takahisa Gono Myositis related ILD: from bench to bedside Takuya Kotani Improving IIM classification criteria: where are we now? Jessica Day Q&A |
Paedatric rheumatology workforce: fill the gap
session
Coordinated by the APLAR Paediatric SIG Innovations in training Sirirat Charuvanij COE: blueprint for lesser mortals Surjit Singh Q&A |
Genetics session
Coordinated by the APLAR Genetics SIG Chairpersons: Michael Tee and Chikashi Terao Genetic approach to identify new targeted therapies in SLE Prapaporn Pisitkun Personalised medicine in rheumatology: leveraging genetic insights to disease predict Yi-Ming Chen Genetic polymorphism in rheumatoid arthritis Suleman Khan Q&A |
|
|
1550-1615 |
BREAK AND POSTER VIEWING |
||||
|
1615-1730 |
|||||
|
EULAR session: Early diagnosis and management of arthritis
Chairpersons: Yoshiya Tanaka A journey through recent EULAR management recommendations Anna-Maria Iagnocco Early RA diagnosis - where are we now? Daniel Aletaha Modern imaging tools for early SpA diagnosis Xenofon Baraliakos Q&A |
AYR session
Coordinated by the AYR SIG Chairpersons: Priscilla Wong and Himantha Atukorale Immunodeficiencies presenting to the rheumatology clinic Justina Tan A novel approach to anti-cytokine sydnromes - when autoimmunity presents as infections out of the blue Xin Li Q&A |
Rheumatology potpourri 1
Chairpersons: Steven Sawyers and Nuntana Kasitanon Biomarker and immunology aspect in fibromyalgia Geoffrey Littlejohn Metabolomic in rheumatic diseases Ramnath Misra Sleep disorders in rheumatic diseases Zhifeng Gu |
Women's Health & Reproductive Issues in RMDs
Coordinated by the Reproductive SIG Chairpersons: Rohini Handa Introduction into pregnancy and rheumatic disease with focus on SLE and APLS Samar Al-Emadi Inflammatory arthritis including RA, SpA (efect of the disease on pregnancy and fetal comes) Mu Rong Q&A |
||
|
1800-1900 |
Evening symposium 1 |
Evening symposium 2 |
Evening symposium 3 |
|
|
|
ROOM Capacity |
Exhibition Hall 1 2,000 capacity |
Convention Hall 1 1,700 capacity |
Leelawadee Hall 1 400 theatre capacity |
Leelawadee Hall 2 400 theatre capacity |
B1 100 theatre capacity |
Exhibition Hall 3 |
|---|---|---|---|---|---|---|
|
0800-0900 |
|
|
|
|
|
|
|
0900-1030 |
|
|
||||
|
1030-1055 |
|
BREAK AND POSTER VIEWING |
||||
|
1055-1200 |
Morning symposium 1 Sponsored by AbbVie |
Morning symposium 2 |
Morning symposium 3 |
Morning symposium 4 |
|
|
|
1200-1315 |
Concurrent session SIG Rheumatoid arthritis |
Concurrent session SIG Vasculitis |
Concurrent session COVID-19 infection and rheumatic diseases |
Concurrent session Personalized treatment in idiopathic inflammatory myopathy (IIM) |
Concurrent session SIG Sjogren |
|
|
1315-1435 |
Lunch symposium 1 Sponsored by Pfizer |
Lunch symposium 2 |
|
1320-1350 Meet the experts 1 Sponsored by GSK |
||
|
1400-1430 Meet the experts 2 Sponsored by Boehringer Ingelheim |
||||||
|
1435-1550 |
Concurrent session 1. Update treatment in osteoporosis Sequential and combination of osteoporosis therapy Denosumab discontinuation 2.Osteoporosis treatment and cardiovascular effects Relationship of bone and cardiovascular system Cardiovascular effects of osteoporosis therapies |
Concurrent session SIG Myositis Update on idiopathic inflammatory myopathy diagnosis From pathology to diagnosis Myositis specific antibodies in IIM and clinical relevance |
Concurrent session SIG Pediatric Children with rheumatic diseases during COVID-19 era Immunogenicity and effectiveness of COVID-19 vaccination Outcomes of autoimmune diseases after COVID-19 infection/vaccination |
Concurrent session IgG4 related disease Updated mechanisms Perspective treatment Myositis specific antibodies in IIM and clinical relevance |
||
|
0800-0900 |
Advanced therapy in rheumatic diseases
Chairpersons: Lai-Shan Tam and Andrea Low Treatment of non-radiographic axial spondyloarthritis: which kinds of medicine should be the most appropriate treatment for non-radiographic axial spondyloarthritis and when to start? Mitsumasa Kishimoto |
Abstract session
|
Abstract session
|
|
0900-1030 |
Plenary session 3
Chairpersons: Rohini Handa and Yi-Hsing Chen Rational DMARDs use in Asian context Tsutomu Takeuchi How to taper and/or discontinue DMARDs (csDMARDs, biologics and JAKi) in RA patients with sustained remission Daniel Aletaha Non-selective vs selective JAK inhibitors for RA: effectiveness and safety Peter Nash |
||
|
1030-1100 |
BREAK AND POSTER VIEWING |
||
|
1100-1200 |
Personalized treatment in idiopathic inflammatory myopathy (IIM)
Chairpersons: Latika Gupta and Jasmin Raja IIM associated ILD Hideaki Tsuji Malignancy screening and treatment for IIM associated cancer Guochun Wang |
|
Rheumatology Potpourri 2
Chairpersons: Yi-Hsing Chen and Nuntana Kasitanon Renal and neurological problems in Sjogren's syndrome Sandhya Pulukool Imaging in large vessel vasculitis Naoto Tamura |
|
1200-1315 |
Osteoarthritis session
Coordinated with the APLAR Osteoarthritis SIG Chairpersons: Keith Lim Joint effusions and knee OA Keith Lim TBA Changhai Ding Predictors of response Benny Antony Q&A |
Recent advances in psoriatic arthritis
Coordinated by the APLAR SpA SIG Chairpersons: Nizar Abdulateef Jassim and Kichul Shin State of the art therapeutics for PsA Lai-Shan Tam Precision medicine in predicting treatment response in psoriatic arthritis Ippei Miyagawa Role of MRI in PsA Ashish Mathew Q&A |
Social commitment and patient outreach session
Coordinated by the Social commitment and patient outreach SIG Chairpersons: Syed Atiqul Haq and Nighat Ahmad Introduction Syed Atiqul Haq and Nighat Ahmad Educating patients: show should a rheumatology proceed A T M Tanveer Hasan The HomeRheum Status: Current state of rheumatology workforce in Asia-Pacific Jonathan Paul Consignado Q&A Closing remarks Syed Atiqul Haq and Nighat Ahmad |
|
1315-1415 |
|||
|
BREAK AND POSTER VIEWING |
|||
|
1415-1530 |
Best management of SLE
Coordinated by the SLE SIG Chairpersons: CC Mok and Yoshiya Tanaka Impact of ethnic and social inequity on outcome of SLE Sarfaraz Hasni Assessment of disease activity of SLE Kathryn Connelly COVID-19 in SLE Syahrul Sazliyana Successful pregnancy and gender equity in SLE Sandra Navarra Q&A |
Rheumatoid arthritis session
Coordinated by the RA SIG Chairpersons: Kunihiro Yamaoaka Recommendation update Kunihiro Yamaoka Improvement of early diagnosis and management of rheumatoid arthritis using digital health system Chun Li Q&A |
Emerging treatment strategies for osteoporosis
Coordinated by the Osteoporosis SIG Chairpersons: Lau Tang Ching and Sumapa Chaiamnuay What is hot and what is not in bone? Kenneth Saag Debate - treat or target for osteoporosis, myth or reality? Lau Tang Ching and Sumapa Chaimnuay Q&A |
|
1530-1600 |
BREAK AND POSTER VIEWING |
||
|
1600-1715 |
Digital health and clinical decision support system in rheumatology
Best management of SLE
Coordinated by the Digital Health and Telemedicine SIG Chairpersons: Yew Kuang Cheng Why should we use artificial intelligence in rheumatic disease? Sakir Ahmed Artificial intelligence implication in rheumatic diseases Lisa Traboco |
Current evidence of osteoarthritis management
Chairpersons: Nazrul Islam and Keith Lim Update pathogenesis of osteoarthritis Inoshi Atukorala Update treatment in osteoarthritis Syed Atiqul Haq What's new in hand osteoarthritis? Benny Anthony |
Crystal induced arthritis session
Coordinated by the Crystal induced arthritis SIG Chairpersons: Helen Keen and Jose Paulo Lorenzo The intersection of gout and chronic kidney disease Evelyn Salido Gaos in the current knowledge of evalutation and treatment of gout Binit Vaidya CPPD the ignored disease Sami Salmon APLAR gout registry updates and preliminary results Kanon Jatuworapruk Q&A |
|
1715-1830 |
Pain in rheumatic musculoskeletal disorders: A COPCORD perspective
Coordinated by the Epidemiology COPCORD SIG Chairpersons: Arvind Chopra and Samar Al-Emadi What a pain it is! Arvind Chopra Pain beyond inflammation in rheumatic disorders Shin-Seok Lee Lessons on capturing pain from COPCORD studies Leonila Dans Epidemiology of fibromyalgia in rheumatic diseases Soosan Soroosh br> Sex differences in perception of pain in the COPCORD domain Binit Vaidya Future COPCORD research agenda for pain in rheumatic diseases Ashish Mathew Q&A |
Gout in women
Chairpersons: Jose Paulo Lorenzo and Worawit Louthrenoo Urate biology Helen Keen Clinical presentations and management Monika De Silva Patient preferences in gout management Jisoo Lee |
Chronic pain session
Coordinated by the Chronic pain SIG |
|
1930-2130 |
Joint Presidential & Gala Dinner
Not included in registration. Tickets available at additional cost. View more information and registration information here |
||
|
0800-0900 |
Relapse of adult-onset Still disease
Chairpersons: Wafa Wadanat and Samar Al-Emadi Genetics and risk factors Alireza Khabbazi How to treat and efficacy of tight control Dae Hyun Yoo |
Gout session
Chairpersons: Helen Keen and Ronald Yip Emerging strategies for treating difficult gout Worawit Louthrenoo |
Abstract session
|
|
0900-1030 |
Plenary session 4
Chairpersons: Laniyati Hamijoyo and Sandra Navarra Future direction of optimal treatment in SLE Eric Morand TBA Nan Shen New concepts of lupus nephritis treatment CC Mok |
||
|
1030-1050 |
BREAK AND POSTER VIEWING |
||
|
1050-1205 |
Imaging SIG session
Chairpersons: Kong Kok Ooi and Phonpen Akarawatcharangura Goo Ultrasonography in large vessel vasculitis (US LVV) - an update Helen Keen Ultrasonography in Systemic Lupus Erythematosus Farzana Shumy Q&A |
Hot topics in rheumatoid arthritis
Chairpersons: Manathip Osiri and Cho Mar Lwin Advances in biological targets in RA Kazuhiko Yamamoto Should csDMARDs be maintained lifelong after sustained remission? Mu Rong |
Highlights in Paediatric Rheumatology
Chairpersons: Sumaira Farman Cytokine storms: similarities and dissimilarities between MAS and MIS-C Soamarat Vilaiyuk COVID-19 vaccination in pediatric rheumatic diseases: whre are we going forward? Thaschawee Arkachaisri Autoinflammatory diseases in Asian Pacific: are we different? Sulaiman Al-Mayouf |
|
1205-1305 |
|||
|
BREAK AND POSTER VIEWING |
|||
|
1305-1420 |
|||
|
Reproductive aspects in rheumatic disease
Chairpersons: Adeeba Al-Herz Reproductive health in inflammatory arthritis Samar Al-Emadi Reproductive health and biologics Latika Gupta Pregnancy outcomes in SLE Sandra Navarra |
ACR session
|
Updating Imaging in rheumatology
Chairpersons: Katy Leung and Gavin Lee Imaging modalities for CNS vasculitis evaluation Naoto Tamura Imaging update in spondyloarthritis Ashish Jacob Mathew Imaging update in osteoarthritis Hyun Ah Kim |
|
|
1420-1440 |
|||
|
BREAK AND POSTER VIEWING |
|||
|
1440-1555 |
COVID-19 and beyond
Chairpersons: Sandhya Pulukool and Kichul Shin Autoimmunity after COVID infection Prapaporn Pisitkun Comparative outcome of patients with rheumatic disease affected by COVID-19 infection Kuo-Tung Tang COVID epidemiology and its relationship with rheumatic diseases Catherine Hill |
Recent understanding and perspective of Sjogren's syndrome
Coordinated by the APLAR Sjogren SIG Chairpersons: Sapan Padya GWAS in Sjogren Maureen Rischmueller Recent understanding and perspective of Sjogren's syndrome Atsushi Kawakami Q&A |
What's new in osteoporosis?
Chairpersons: Sumapa Chaiamnuay and Lau Tang Ching Epidemiology of bone health in patients with rheumatic diseases Arvind Chopra New evidence of bone safety of glucocorticoids in the treatment of inflammatory rheumatic disease Kenneth Saag Long-term management strategies for osteoporosis: continuous or intermittent? Mustafa Khalid Al Izzi |
|
1555-1625 |
Closing Ceremony |
||
